TrialMayo Clinic proceedings2009

Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component.

John A Lust et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.